GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Atf3 | rn6_v1_chr13_-_109844359_109844359 | -0.36 | 4.2e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_82775691 Show fit | 34.40 |
ENSRNOT00000030737
|
histone linker H1 domain, spermatid-specific 1 |
|
chr2_-_127778202 Show fit | 30.53 |
ENSRNOT00000092191
ENSRNOT00000093683 |
similar to RIKEN cDNA 1700034I23 |
|
chr4_+_79055280 Show fit | 29.01 |
ENSRNOT00000086307
|
serine threonine kinase 31 |
|
chr14_-_21748356 Show fit | 28.23 |
ENSRNOT00000002670
|
calcium binding protein, spermatid associated 1 |
|
chr4_+_70977556 Show fit | 26.36 |
ENSRNOT00000031984
|
hypothetical protein LOC680112 |
|
chr8_-_115263484 Show fit | 25.53 |
ENSRNOT00000039696
ENSRNOT00000081138 |
IQ motif containing F3 |
|
chr5_+_131719922 Show fit | 23.27 |
ENSRNOT00000010524
|
spermatogenesis associated 6 |
|
chr8_-_115274165 Show fit | 22.84 |
ENSRNOT00000056386
|
IQ domain-containing protein F5-like |
|
chr3_+_143129248 Show fit | 22.42 |
ENSRNOT00000006667
|
cystatin 8 |
|
chr7_+_20462081 Show fit | 22.14 |
ENSRNOT00000088383
|
|
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 164.2 | GO:0007283 | spermatogenesis(GO:0007283) |
1.2 | 99.9 | GO:0030317 | sperm motility(GO:0030317) |
4.3 | 85.4 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.8 | 81.9 | GO:0007286 | spermatid development(GO:0007286) |
1.8 | 52.0 | GO:0030261 | chromosome condensation(GO:0030261) |
2.9 | 49.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.5 | 36.2 | GO:0031572 | mitotic G2 DNA damage checkpoint(GO:0007095) G2 DNA damage checkpoint(GO:0031572) |
3.6 | 36.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
2.5 | 32.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
1.4 | 31.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 166.2 | GO:0031514 | motile cilium(GO:0031514) |
1.2 | 129.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
3.7 | 88.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
4.2 | 76.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 61.0 | GO:0005813 | centrosome(GO:0005813) |
0.6 | 53.4 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
2.7 | 51.2 | GO:0001520 | outer dense fiber(GO:0001520) |
1.8 | 40.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.8 | 36.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
5.2 | 31.0 | GO:0071547 | piP-body(GO:0071547) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 90.9 | GO:0003677 | DNA binding(GO:0003677) |
5.1 | 76.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 56.7 | GO:0042393 | histone binding(GO:0042393) |
0.7 | 47.9 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
1.5 | 46.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.4 | 44.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 35.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 34.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
1.6 | 32.1 | GO:0008199 | ferric iron binding(GO:0008199) |
7.3 | 29.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 47.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 33.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 24.4 | PID MYC PATHWAY | C-MYC pathway |
1.7 | 23.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 16.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 12.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 9.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 8.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 7.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 7.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 65.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.9 | 38.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 35.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 31.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 30.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 26.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.3 | 22.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.6 | 17.1 | REACTOME KINESINS | Genes involved in Kinesins |
1.2 | 15.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.9 | 14.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |